Lara Sullivan - Net Worth and Insider Trading
Lara Sullivan Net Worth
The estimated net worth of Lara Sullivan is at least $9 Million dollars as of 2024-11-05. Lara Sullivan is the President and CEO of Pyxis Oncology Inc and owns about 2,403,882 shares of Pyxis Oncology Inc (PYXS) stock worth over $9 Million. Details can be seen in Lara Sullivan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lara Sullivan has not made any transactions after 2023-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lara Sullivan
Lara Sullivan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lara Sullivan owns 3 companies in total, including Rexahn Pharmaceuticals Inc (REXN) , Opus Genetics Inc (IRD) , and Pyxis Oncology Inc (PYXS) .
Click here to see the complete history of Lara Sullivan’s form 4 insider trades.
Insider Ownership Summary of Lara Sullivan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REXN | Rexahn Pharmaceuticals Inc | 2019-06-06 | director |
| IRD | Opus Genetics Inc | 2019-02-27 | director |
| PYXS | Pyxis Oncology Inc | 2023-09-18 | director & Chief Executive Officer |
Lara Sullivan Latest Holdings Summary
Lara Sullivan currently owns a total of 1 stock. Lara Sullivan owns 2,403,882 shares of Pyxis Oncology Inc (PYXS) as of September 18, 2023, with a value of $9 Million.
Latest Holdings of Lara Sullivan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PYXS | Pyxis Oncology Inc | 2023-09-18 | 2,403,882 | 3.84 | 9,230,907 |
Holding Weightings of Lara Sullivan
Lara Sullivan Form 4 Trading Tracker
According to the SEC Form 4 filings, Lara Sullivan has made a total of 2 transactions in Pyxis Oncology Inc (PYXS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Pyxis Oncology Inc is the sale of 8,641 shares on September 18, 2023, which brought Lara Sullivan around $18,146.
Insider Trading History of Lara Sullivan
- 1
Lara Sullivan Trading Performance
Lara Sullivan Ownership Network
Ownership Network List of Lara Sullivan
Ownership Network Relation of Lara Sullivan
Lara Sullivan Owned Company Details
What does Rexahn Pharmaceuticals Inc do?
Who are the key executives at Rexahn Pharmaceuticals Inc?
Lara Sullivan is the director of Rexahn Pharmaceuticals Inc. Other key executives at Rexahn Pharmaceuticals Inc include Chief Medical Officer Ely Benaim , Chief Business Officer Lisa Nolan , and director & President and CEO Douglas J Swirsky .
Rexahn Pharmaceuticals Inc (REXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rexahn Pharmaceuticals Inc (REXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rexahn Pharmaceuticals Inc (REXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rexahn Pharmaceuticals Inc (REXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rexahn Pharmaceuticals Inc Insider Transactions
Lara Sullivan Mailing Address
Above is the net worth, insider trading, and ownership report for Lara Sullivan. You might contact Lara Sullivan via mailing address: C/o Rexahn Pharmaceuticals, Inc., 15245 Shady Grove Road, Suite 455, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
